‌Welcome and Introduction from the Interim Chair

Research in the Department of Molecular Pharmacology and Neuroscience focuses on fundamental cellular and molecular mechanisms underlying a wide range of diseases.  We have a long history of major advancements in many areas (see the next section), including the etiology and treatment of patients with cancer, asthma, heart failure, diabetes, traumatic brain injury, stroke, and neurodegenerative diseases.  More recently, researchers in the department are taking advantage of the ground-breaking advances in RNA biology and the new discipline pharmacovigilance. We are among the pioneers in these rapidly developing areas of molecular therapeutics. We have strong working relationships with industry partners in the Chicagoland area, which provide additional avenues for research and for training of future scientists seeking careers in the pharmaceutical industry.

Mission Statement:  To advance basic and translational research in the Pharmacological and Medical Sciences, with a focus upon improving patient outcomes with new therapies. A second and equally important mission is to educate the next generation of physicians and research scientists so that they will have the knowledge and skills to extend and advance these aspects of biomedical science to improve the health of all human populations well into the future. We also seek to reduce disparity in education, research, and patient care by appropriate application and dissemination of new knowledge. 

About the Department 

The Department of Molecular Pharmacology and Neuroscience at Loyola has a storied history with current primary research foci in cardiovascular and neuropharmacology, precision diagnostics, and therapeutics related to hemostasis and thrombosis.  Since all of these areas require therapeutic target discovery and pre-clinical research, our research is not defined by one organ or disorder but rather the molecular functions that underlie biological processes and disease mechanisms. Accordingly, we are a dynamic department, always engaging in new areas that offer interdisciplinary and collaborative research opportunities.  What we all share in common is an interest in discovering the molecular basis of disease, identifying therapeutic targets and using our research to test potential therapeutic solutions.  Since our research spans the gamut from basic science to translational research and early clinical studies, we are among those who develop the medicines and the novel therapeutic approaches of tomorrow.

Dr. Kenneth L. Byron, Professor and Interim Chair